Acute pain in peripheral vascular disease

2011 ◽  
Author(s):  
Arif H. Ghazi ◽  
Obi Agu
Keyword(s):  
Pain Relief ◽  
Vascular Disease ◽  
Peripheral Vascular Disease ◽  
Acute Pain ◽  
Peripheral Vascular ◽  
Surgical Revascularization ◽  
End Stage

Pain in vascular disease is often severe. Atherosclerosis is the commonest cause of ischaemic pain. Angioplasty, stents, and surgical revascularization should be attempted to treat the underlying cause. Pain relief is also aimed at neuropathic and sympathetic components of pain. In end stage ischaemic disease, amputation may be necessary often leading to long-term pain.

Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients

2001 ◽  
Vol 38 (1) ◽  
pp. 57-63 ◽  
Author(s):  
Donal N. Reddan ◽  
Richard J. Marcus ◽  
William F. Owen ◽  
Lynda A. Szczech ◽  
Douglas M. Landwehr
Keyword(s):  
Renal Disease ◽  
Vascular Disease ◽  
Peripheral Vascular Disease ◽  
End Stage Renal Disease ◽  
Peripheral Vascular ◽  
Long Term Outcomes ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Patient characteristics predict patency of early-cannulation arteriovenous grafts

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
David B. Kingsmore ◽  
Karen S. Stevenson ◽  
S. Richarz ◽  
Andrej Isaak ◽  
Andrew Jackson ◽  
...  
Keyword(s):  
Vascular Disease ◽  
Peripheral Vascular Disease ◽  
Vascular Access ◽  
Demographic Data ◽  
Univariate Analysis ◽  
Patient Characteristics ◽  
Peripheral Vascular ◽  
Arteriovenous Grafts ◽  
One Year

AbstractThere is a new emphasis on tailoring appropriate vascular access for hemodialysis to patients and their life-plans, but there is little known about the optimal use of newer devices such as early-cannulation arteriovenous grafts (ecAVG), with studies utilising them in a wide variety of situations. The aim of this study was to determine if the outcome of ecAVG can be predicted by patient characteristics known pre-operatively. This retrospective analysis of 278 consecutive ecAVG with minimum one-year follow-up correlated functional patency with demographic data, renal history, renal replacement and vascular access history. On univariate analysis, aetiology of renal disease, indication for an ecAVG, the number of previous tunnelled central venous catheters (TCVC) prior to insertion of an ecAVG, peripheral vascular disease, and BMI were significant associates with functional patency. On multivariate analysis the number of previous TCVC, the presence of peripheral vascular disease and indication were independently associated with outcome after allowing for age, sex and BMI. When selecting for vascular access, understanding the clinical circumstances such as indication and previous vascular access can identify patients with differing outcomes. Importantly, strategies that result in TCVC exposure have an independent and cumulative association with decreasing long-term patency for subsequent ecAVG. As such, TCVC exposure is best avoided or minimised particularly when ecAVG can be considered.

Peripheral Vascular Disease in Diabetic Peritoneal Dialysis Patients

2007 ◽  
Vol 27 (2_suppl) ◽  
pp. 210-214 ◽  
Author(s):  
Heikki H.T. Saha ◽  
Yrjö K.J. Leskinen ◽  
Juha P. Salenius ◽  
Jorma T. Lahtela
Keyword(s):  
Peritoneal Dialysis ◽  
Vascular Disease ◽  
Peripheral Vascular Disease ◽  
Current Knowledge ◽  
Diabetic Patients ◽  
Peripheral Vascular ◽  
Dialysis Patients ◽  
Stage Renal Disease ◽  
End Stage ◽  
Review Current

In the present article, we review current knowledge of the epidemiology, diagnosis, and treatment of peripheral vascular disease in patients with end-stage renal disease. The main focus is placed on diabetic patients receiving peritoneal dialysis, but studies on patients receiving hemodialysis are also reviewed, because most reports involve this patient group, and the number of reports on peripheral vascular disease in PD patients alone is limited.

Pain relief in peripheral vascular disease with spinal cord stimulation: Five years experience

Pain ◽  
1984 ◽  
Vol 18 ◽  
pp. S80
Author(s):  
J. A. de Vera ◽  
F. Robaina ◽  
J. L. Rodrigues ◽  
M. A. Martin
Keyword(s):  
Spinal Cord ◽  
Pain Relief ◽  
Vascular Disease ◽  
Peripheral Vascular Disease ◽  
Spinal Cord Stimulation ◽  
Peripheral Vascular

The Behaviour of Various Platelet Function Tests During Long-Term Prostacyclin Infusion in Patients with Peripheral Vascular Disease

1983 ◽  
Vol 50 (04) ◽  
pp. 885-887 ◽  
Author(s):  
H Sinzinger ◽  
A K Horsch ◽  
K Silberbauer
Keyword(s):  
Platelet Count ◽  
Vascular Disease ◽  
Peripheral Vascular Disease ◽  
Platelet Function ◽  
Peripheral Vascular ◽  
Platelet Function Tests ◽  
Function Tests ◽  
Induced Aggregation ◽  
Significant Activation

SummaryIn 20 patients with peripheral vascular disease treated with prostacyclin (5 ng/kg/min) we observed a significant activation of platelet function as measured by platelet proteins, ADP- induced aggregation platelet sensitivity and platelet count. Only the platelet survival was significantly prolonged by the treatment.

Peripheral Vascular Disease Intervention in Patients With End-Stage Renal Disease

2001 ◽  
Vol 94 (10) ◽  
pp. 1002-1005
Author(s):  
KELLY L. McCOY ◽  
DAVID R. GOLDSTEIN ◽  
VIVIAN GAHTAN ◽  
GREGORY MAYRO ◽  
MORRIS D. KERSTEIN
Keyword(s):  
Renal Disease ◽  
Vascular Disease ◽  
Peripheral Vascular Disease ◽  
End Stage Renal Disease ◽  
Peripheral Vascular ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document